Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
67.6M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
44.1M
-
Shares change
-
-3.54M
-
Total reported value, excl. options
-
$93.9M
-
Value change
-
-$10.5M
-
Put/Call ratio
-
0.82
-
Number of buys
-
44
-
Number of sells
-
-75
-
Price
-
$2.13
Significant Holders of Perspective Therapeutics, Inc. - Common Stock (CATX) as of Q1 2025
151 filings reported holding CATX - Perspective Therapeutics, Inc. - Common Stock as of Q1 2025.
Perspective Therapeutics, Inc. - Common Stock (CATX) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.1M shares
of 67.6M outstanding shares and own 65.21% of the company stock.
Largest 10 shareholders include FMR LLC (10.1M shares), BlackRock, Inc. (3.97M shares), VANGUARD GROUP INC (3.07M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.83M shares), Octagon Capital Advisors LP (2.25M shares), Affinity Asset Advisors, LLC (2.22M shares), Avidity Partners Management LP (2.2M shares), Nicholson Wealth Management Group, LLC (1.61M shares), MORGAN STANLEY (1.56M shares), and Nuveen, LLC (1.24M shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.